Cart 0

QY Research

China Hematological Cancers Market Research Report 2017

$3,200.00

Report Published By: QY Research
Publication Date : Feb-17
No. Of Pages: 124

Notes:
Sales, means the sales volume of Hematological Cancers
Revenue, means the sales value of Hematological Cancers

This report studies Hematological Cancers in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Karyopharm Therapeutics
Johnson & Johnson
Roche Diagnostics A/S
AbbVie
Novartis
Kite Pharma
Celgene Corporation
Abbott Laboratories
Beckman Coulter
HemoCue AB
C. R. Bard
Siemens AG
Sysmex
Mindray Medical International Limited
Bio-Rad Laboratories
The Medicine Company
Pharmacyclics
Horiba
DiagnoCure Inc.
Astellas Pharma US

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Pharmacological Therapies
Stem Cell Transplantation
Surgery and Radiation Therapy
Anemia Treatment
Thrombosis Treatment
Neutopenia Treatment
Symptomatic treatment
Split by Application, this report focuses on consumption, market share and growth rate of Hematological Cancers in each application, can be divided into
Epidemiology
Pathophysiology of Leukemic Stem Cells
Kidney Diseases
Genetic Diseases
Other Diseases

Table of Contents

China Hematological Cancers Market Research Report 2017
1 Hematological Cancers Market Overview
1.1 Product Overview and Scope of Hematological Cancers
1.2 Hematological Cancers Segment by Type
1.2.1 China Production Market Share of Hematological Cancers Type in 2015
1.2.2 Pharmacological Therapies
1.2.3 Stem Cell Transplantation
1.2.4 Surgery and Radiation Therapy
1.2.5 Anemia Treatment
1.2.6 Thrombosis Treatment
1.2.7 Neutopenia Treatment
1.2.8 Symptomatic treatment
1.3 Applications of Hematological Cancers
1.3.1 Hematological Cancers Consumption Market Share by Application in 2015
1.3.2 Epidemiology
1.3.3 Pathophysiology of Leukemic Stem Cells
1.3.4 Kidney Diseases
1.3.5 Genetic Diseases
1.3.6 Other Diseases
1.4 China Market Size (Value) of Hematological Cancers (2012-2022)
1.5 China Hematological Cancers Status and Outlook
1.6 Government Policies

2 China Hematological Cancers Market Competition by Manufacturers
2.1 China Hematological Cancers Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Hematological Cancers Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Hematological Cancers Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Hematological Cancers Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hematological Cancers Market Competitive Situation and Trends
2.5.1 Hematological Cancers Market Concentration Rate
2.5.2 Hematological Cancers Market Share of Top 3 and Top 5 Manufacturers

3 China Hematological Cancers Manufacturers Profiles/Analysis
3.1 Karyopharm Therapeutics
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Hematological Cancers Product Type, Application and Specification
3.1.2.1 Pharmacological Therapies
3.1.2.2 Stem Cell Transplantation
3.1.3 Karyopharm Therapeutics Hematological Cancers Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Johnson & Johnson
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Hematological Cancers Product Type, Application and Specification
3.2.2.1 Pharmacological Therapies
3.2.2.2 Stem Cell Transplantation
3.2.3 Johnson & Johnson 124 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Roche Diagnostics A/S
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Hematological Cancers Product Type, Application and Specification
3.3.2.1 Pharmacological Therapies
3.3.2.2 Stem Cell Transplantation
3.3.3 Roche Diagnostics A/S 130 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 AbbVie
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Hematological Cancers Product Type, Application and Specification
3.4.2.1 Pharmacological Therapies
3.4.2.2 Stem Cell Transplantation
3.4.3 AbbVie Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Novartis
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Hematological Cancers Product Type, Application and Specification
3.5.2.1 Pharmacological Therapies
3.5.2.2 Stem Cell Transplantation
3.5.3 Novartis Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Kite Pharma
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Hematological Cancers Product Type, Application and Specification
3.6.2.1 Pharmacological Therapies
3.6.2.2 Stem Cell Transplantation
3.6.3 Kite Pharma Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Celgene Corporation
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Hematological Cancers Product Type, Application and Specification
3.7.2.1 Pharmacological Therapies
3.7.2.2 Stem Cell Transplantation
3.7.3 Celgene Corporation Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Abbott Laboratories
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Hematological Cancers Product Type, Application and Specification
3.8.2.1 Pharmacological Therapies
3.8.2.2 Stem Cell Transplantation
3.8.3 Abbott Laboratories Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Beckman Coulter
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Hematological Cancers Product Type, Application and Specification
3.9.2.1 Pharmacological Therapies
3.9.2.2 Stem Cell Transplantation
3.9.3 Beckman Coulter Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 HemoCue AB
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Hematological Cancers Product Type, Application and Specification
3.10.2.1 Pharmacological Therapies
3.10.2.2 Stem Cell Transplantation
3.10.3 HemoCue AB Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 C. R. Bard
3.12 Siemens AG
3.13 Sysmex
3.14 Mindray Medical International Limited
3.15 Bio-Rad Laboratories
3.16 The Medicine Company
3.17 Pharmacyclics
3.18 Horiba
3.19 DiagnoCure Inc.
3.20 Astellas Pharma US

4 China Hematological Cancers Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Hematological Cancers Capacity, Production and Growth (2012-2017)
4.2 China Hematological Cancers Revenue and Growth (2012-2017)
4.3 China Hematological Cancers Production, Consumption, Export and Import (2012-2017)

5 China Hematological Cancers Production, Revenue (Value), Price Trend by Type
5.1 China Hematological Cancers Production and Market Share by Type (2012-2017)
5.2 China Hematological Cancers Revenue and Market Share by Type (2012-2017)
5.3 China Hematological Cancers Price by Type (2012-2017)
5.4 China Hematological Cancers Production Growth by Type (2012-2017)

6 China Hematological Cancers Market Analysis by Application
6.1 China Hematological Cancers Consumption and Market Share by Application (2012-2017)
6.2 China Hematological Cancers Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaHematological Cancers Market Analysis by Regions (Provinces)
7.1 China Hematological Cancers Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Hematological Cancers Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Hematological Cancers Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Hematological Cancers Sales Price by Regions (Provinces)(2012-2017)
7.2 China Hematological Cancers Consumption by Regions (Provinces)(2012-2017)
7.3 China Hematological Cancers Production, Consumption, Export and Import (2012-2017)

8 Hematological Cancers Manufacturing Cost Analysis
8.1 Hematological Cancers Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Hematological Cancers

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Hematological Cancers Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Hematological Cancers Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Hematological Cancers Market Forecast (2017-2022)
12.1 China Hematological Cancers Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Hematological Cancers Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Hematological Cancers Production Forecast by Type (2017-2022)
12.4 China Hematological Cancers Consumption Forecast by Application (2017-2022)
12.5 China Hematological Cancers Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Hematological Cancers Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Hematological Cancers Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Hematological Cancers Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Hematological Cancers Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


* indicates required information

* indicates required information


Share this Product


More from this collection